Ask Warren

Hanmi Pharm

128940 · KOSPI · ₩128940 · 한미약품

₩369,500▲ ₩19,000 (5.42%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me
SellBuy

Filings

  • Share cancellation decision주식소각결정

    Predicted impact: Medium

    Share cancellation decision with no size given; could matter if large versus market value.

    Oct 27, 2026Open on DART
  • Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)

    Predicted impact: Medium

    Official preliminary earnings filing; same results already reported in headlines.

    Oct 27, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최(안내공시)

    Predicted impact: Low

    Oct 16, 2026Open on DART
  • Advance Notice of Earnings Results Disclosure (Informational Disclosure)결산실적공시예고(안내공시)

    Predicted impact: Low

    Oct 16, 2026Open on DART
  • Major management matter relevant to investors투자판단관련주요경영사항 (에페오토인젝터주(에페글레나타이드) 식품의약품안전처 품목허가 승인)Oct 7, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 6, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(약식)Oct 2, 2026Open on DART
  • Major management matter relevant to investors투자판단관련주요경영사항Sep 29, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Sep 29, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 29, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최(안내공시)Sep 8, 2026Open on DART
  • Change in largest shareholder's holdings최대주주등소유주식변동신고서Sep 8, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Sep 8, 2026Open on DART
  • Change in largest shareholder's holdings최대주주등소유주식변동신고서Aug 28, 2026Open on DART
  • Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항 (급성골수성백혈병(AML) 치료 항암신약 HM43239 기술이전 계약 체결)Aug 26, 2026Open on DART
  • Major management matter relevant to investors투자판단관련주요경영사항Aug 24, 2026Open on DART
  • Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항Aug 21, 2026Open on DART
  • Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항Aug 21, 2026Open on DART
  • Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Aug 12, 2026Open on DART
  • Change in largest shareholder's holdings최대주주등소유주식변동신고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Report on Results of Disposal of Treasury Shares자기주식처분결과보고서Aug 7, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 3, 2026Open on DART
  • Fair Trade Self-Compliance Program Operation Status (Informational Disclosure)공정거래자율준수프로그램운영현황(안내공시)Jul 31, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최(안내공시)Jul 30, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최(안내공시)Jul 30, 2026Open on DART
  • Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Jul 28, 2026Open on DART

Titles in Korean until English translations are added.

Also known as: Hanmi Pharm / 한미약품 / 128940 / KRX:128940

Source: KRX statistical information